Modeling the epidemiology and economics of directly observed therapy in Baltimore

C. Patrick Chaulk, M. Friedman, R. Dunning

Research output: Contribution to journalArticle

Abstract

SETTING: From 1958 to 1978, Baltimore maintained one of the highest pulmonary tuberculosis (TB) rates in the US. But, from 1978 to 1992 its TB rate declined by 64.3% and its ranking for TB fell from second highest among large US cites to twenty-eighth. This TB trend coincided with the implementation of an aggressive directly observed therapy (DOT) program by Baltimore's Health Department. OBJECTIVES: We used modeling to estimate the range of TB cases prevented in Baltimore under DOT. Case estimates equal the difference between the observed number of TB cases in Baltimore versus the expected number if Baltimore's TB trend was replaced by the TB trend for the US (low estimate) or the TB trend for all US cities with over 250 000 residents (high estimate). Economic savings are estimated. RESULTS: Without DOT we estimate there would have been between 1577 (53.6%) and 2233 (75.9%) more TB cases in Baltimore, costing $18.8 million to $27.1 million. Cases prevented and expenditures saved increased with increased DOT participation. CONCLUSION: Our model predicts that Baltimore's TB decline accompanying DOT resulted in health care savings equal to twice the city's total TB control budget for this period. These results are most plausibly due to DOT, since it was the only major change in Baltimore's TB control program, and rising TB risk factors - AIDS, injection drug use, poverty - in a city where TB had been epidemic should have triggered a TB increase as in comparable US cities, rather than the observed decline. As national TB rates continue to decline it will be important to identify ways to capture and reinvest these savings to support effective TB control programs.

Original languageEnglish (US)
Pages (from-to)201-207
Number of pages7
JournalInternational Journal of Tuberculosis and Lung Disease
Volume4
Issue number3
StatePublished - Mar 2000

Fingerprint

Directly Observed Therapy
Baltimore
Epidemiology
Tuberculosis
Economics
Anti-HIV Agents

Keywords

  • Community-based treatment
  • Directly observed therapy
  • Economics
  • Health care expenditures
  • Prevention
  • Public health
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Modeling the epidemiology and economics of directly observed therapy in Baltimore. / Chaulk, C. Patrick; Friedman, M.; Dunning, R.

In: International Journal of Tuberculosis and Lung Disease, Vol. 4, No. 3, 03.2000, p. 201-207.

Research output: Contribution to journalArticle

Chaulk, C. Patrick ; Friedman, M. ; Dunning, R. / Modeling the epidemiology and economics of directly observed therapy in Baltimore. In: International Journal of Tuberculosis and Lung Disease. 2000 ; Vol. 4, No. 3. pp. 201-207.
@article{fcbc5c8b48a64a8a85a77b3cb4ba0f31,
title = "Modeling the epidemiology and economics of directly observed therapy in Baltimore",
abstract = "SETTING: From 1958 to 1978, Baltimore maintained one of the highest pulmonary tuberculosis (TB) rates in the US. But, from 1978 to 1992 its TB rate declined by 64.3{\%} and its ranking for TB fell from second highest among large US cites to twenty-eighth. This TB trend coincided with the implementation of an aggressive directly observed therapy (DOT) program by Baltimore's Health Department. OBJECTIVES: We used modeling to estimate the range of TB cases prevented in Baltimore under DOT. Case estimates equal the difference between the observed number of TB cases in Baltimore versus the expected number if Baltimore's TB trend was replaced by the TB trend for the US (low estimate) or the TB trend for all US cities with over 250 000 residents (high estimate). Economic savings are estimated. RESULTS: Without DOT we estimate there would have been between 1577 (53.6{\%}) and 2233 (75.9{\%}) more TB cases in Baltimore, costing $18.8 million to $27.1 million. Cases prevented and expenditures saved increased with increased DOT participation. CONCLUSION: Our model predicts that Baltimore's TB decline accompanying DOT resulted in health care savings equal to twice the city's total TB control budget for this period. These results are most plausibly due to DOT, since it was the only major change in Baltimore's TB control program, and rising TB risk factors - AIDS, injection drug use, poverty - in a city where TB had been epidemic should have triggered a TB increase as in comparable US cities, rather than the observed decline. As national TB rates continue to decline it will be important to identify ways to capture and reinvest these savings to support effective TB control programs.",
keywords = "Community-based treatment, Directly observed therapy, Economics, Health care expenditures, Prevention, Public health, Tuberculosis",
author = "Chaulk, {C. Patrick} and M. Friedman and R. Dunning",
year = "2000",
month = "3",
language = "English (US)",
volume = "4",
pages = "201--207",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "3",

}

TY - JOUR

T1 - Modeling the epidemiology and economics of directly observed therapy in Baltimore

AU - Chaulk, C. Patrick

AU - Friedman, M.

AU - Dunning, R.

PY - 2000/3

Y1 - 2000/3

N2 - SETTING: From 1958 to 1978, Baltimore maintained one of the highest pulmonary tuberculosis (TB) rates in the US. But, from 1978 to 1992 its TB rate declined by 64.3% and its ranking for TB fell from second highest among large US cites to twenty-eighth. This TB trend coincided with the implementation of an aggressive directly observed therapy (DOT) program by Baltimore's Health Department. OBJECTIVES: We used modeling to estimate the range of TB cases prevented in Baltimore under DOT. Case estimates equal the difference between the observed number of TB cases in Baltimore versus the expected number if Baltimore's TB trend was replaced by the TB trend for the US (low estimate) or the TB trend for all US cities with over 250 000 residents (high estimate). Economic savings are estimated. RESULTS: Without DOT we estimate there would have been between 1577 (53.6%) and 2233 (75.9%) more TB cases in Baltimore, costing $18.8 million to $27.1 million. Cases prevented and expenditures saved increased with increased DOT participation. CONCLUSION: Our model predicts that Baltimore's TB decline accompanying DOT resulted in health care savings equal to twice the city's total TB control budget for this period. These results are most plausibly due to DOT, since it was the only major change in Baltimore's TB control program, and rising TB risk factors - AIDS, injection drug use, poverty - in a city where TB had been epidemic should have triggered a TB increase as in comparable US cities, rather than the observed decline. As national TB rates continue to decline it will be important to identify ways to capture and reinvest these savings to support effective TB control programs.

AB - SETTING: From 1958 to 1978, Baltimore maintained one of the highest pulmonary tuberculosis (TB) rates in the US. But, from 1978 to 1992 its TB rate declined by 64.3% and its ranking for TB fell from second highest among large US cites to twenty-eighth. This TB trend coincided with the implementation of an aggressive directly observed therapy (DOT) program by Baltimore's Health Department. OBJECTIVES: We used modeling to estimate the range of TB cases prevented in Baltimore under DOT. Case estimates equal the difference between the observed number of TB cases in Baltimore versus the expected number if Baltimore's TB trend was replaced by the TB trend for the US (low estimate) or the TB trend for all US cities with over 250 000 residents (high estimate). Economic savings are estimated. RESULTS: Without DOT we estimate there would have been between 1577 (53.6%) and 2233 (75.9%) more TB cases in Baltimore, costing $18.8 million to $27.1 million. Cases prevented and expenditures saved increased with increased DOT participation. CONCLUSION: Our model predicts that Baltimore's TB decline accompanying DOT resulted in health care savings equal to twice the city's total TB control budget for this period. These results are most plausibly due to DOT, since it was the only major change in Baltimore's TB control program, and rising TB risk factors - AIDS, injection drug use, poverty - in a city where TB had been epidemic should have triggered a TB increase as in comparable US cities, rather than the observed decline. As national TB rates continue to decline it will be important to identify ways to capture and reinvest these savings to support effective TB control programs.

KW - Community-based treatment

KW - Directly observed therapy

KW - Economics

KW - Health care expenditures

KW - Prevention

KW - Public health

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0034064678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034064678&partnerID=8YFLogxK

M3 - Article

C2 - 10751064

AN - SCOPUS:0034064678

VL - 4

SP - 201

EP - 207

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 3

ER -